We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Three-Dimensional Printing Generates Bone Replacement Structures

By LabMedica International staff writers
Posted on 14 Oct 2016
A team of biomedical engineers adapted three-dimensional printing to manufacture bone transplant structures whose shape could be easily customized, which would be especially useful for the treatment of bone defects in children.

Severe deficiencies remain in current bone replacement materials. More...
These limitations include an inability to adequately, rapidly, and reproducibly regenerate new bone; high costs and limited manufacturing capacity; and lack of surgical ease of handling. To correct this situation, investigators at Northwestern University (Evanston, IL, USA) used room temperature three-dimensional printing to generate a new, synthetic bone replacement biomaterial that they called hyperelastic “bone” (HB). This material, which could be extruded in the form of liquid ink, was composed of 90% hydroxyapatite and 10% polycaprolactone or poly(lactic-co-glycolic acid) polymer. Hydroxyapatite is a calcium mineral found naturally in human bone, while the biocompatible, biodegradable polymers are used in many medical applications, including sutures.

The investigators reported in the September 28, 2016, online edition of the journal Science Translational Medicine that three-dimensionally printed HB exhibited excellent elastic mechanical properties, was highly absorbent, supported cell viability and proliferation, and induced osteogenic differentiation of bone marrow-derived human mesenchymal stem cells cultured in vitro over four weeks without any osteo-inducing factors in the medium.

The investigators evaluated HB in vivo in a mouse subcutaneous implant model for material biocompatibility (seven and 35 days), in a rat posterolateral spinal fusion model for new bone formation (eight weeks), and in a large, non-human primate calvarial defect case study (four weeks). HB did not elicit a negative immune response, became vascularized, quickly integrated with surrounding tissues, and rapidly ossified and supported new bone growth without the need for added biological factors.

“Cells can sense the hydroxyapatite and respond to its bioactivity,” said senior author Dr. Ramille N. Shah, assistant professor of materials science and engineering at Northwestern University. “When you put stem cells on our scaffolds, they turn into bone cells and start to up-regulate their expression of bone-specific genes. This is in the absence of any other osteo-inducing substances. It is just the interaction between the cells and the material itself. We can incorporate antibiotics to reduce the possibility of infection after surgery. We also can combine the ink with different types of growth factors, if needed, to further enhance regeneration. It is really a multi-functional material.”

“Adults have more options when it comes to implants,” said Dr. Shah. “Pediatric patients do not. If you give them a permanent implant, you have to do more surgeries in the future as they grow. They might face years of difficulty.”

Related Links:
Northwestern University


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.